CSF2 and cancer: Its involvement in various diseases has been established, and GM-CSF has been a component in clinical trials (de Souza Vieira et al., 2023), and included in the development of four distinct immunocytokines for cancer therapy (Gasson, 1991; (Lotfi et al., 2019).